Add office photos
Engaged Employer
Dr. Reddy's
4.1
based on 6.7k Reviews
Video summary
Company Overview
Associated Companies
Company Locations
Working at Dr. Reddy's
Company Summary
We are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’
Overall Rating
4.1/5
based on 6.7k reviews
5% above
industry average
Highly rated for
Skill development, Company culture, Salary
Work Policy
Work from office
75% employees reported
Monday to Friday
39% employees reported
Flexible timing
67% employees reported
Within city
37% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
490 employees reported
Health insurance
410 employees reported
Cafeteria
278 employees reported
Child care facility
261 employees reported
View all benefits
About Dr. Reddy's
Founded in1984 (41 yrs old)
India Employee Count10k-50k
Global Employee Count10k-50k
India HeadquartersHyderabad/Secunderabad, Telangana, India
Office Locations
Websitedrreddys.com
Primary Industry
Other Industries
View in video summary
We started in 1984 with a modest investment and a bold vision. Today, with research and development centres, manufacturing facilities and commercial presence across the globe, we serve over half a billion patients worldwide. We aspire to triple our reach and touch over 1.5 billion patients by 2030.
We are committed to providing access to affordable and innovative medicines, driven by our purpose of ‘Good Health Can’t Wait’.
Our products and services are spread across our core businesses of Active Pharmaceutical Ingredients (API), generics, branded generics, biosimilars and over-the-counter pharmaceutical products around the world. We work towards meeting unmet patients needs in the areas of gastro-enterology, cardiovascular, diabetology, oncology, pain management and dermatology. We are investing in businesses of the future including drug discovery, clinically-differentiated assets and digital healthcare.
Dr. Reddy's Ratings
based on 6.7k reviews
Overall Rating
4.1/5
How AmbitionBox ratings work?
5
3.5k
4
1.9k
3
687
2
269
1
386
Category Ratings
4.0
Skill development
3.9
Company culture
3.8
Salary
3.8
Work-life balance
3.7
Work satisfaction
3.6
Job security
3.4
Promotions
Dr. Reddy's is rated 4.1 out of 5 stars on AmbitionBox, based on 6.7k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Dr. Reddy's
based on 6.4k reviews
4.0
Rated by 737 Women
Rated 4.0 for Company culture and 3.8 for Work-life balance
4.1
Rated by 5.7k Men
Rated 4.0 for Skill development and 3.9 for Company culture
Work Policy at Dr. Reddy's
based on 725 reviews in last 6 months
Work from office
75%
Hybrid
21%
Permanent work from home
4%
Dr. Reddy's Reviews
Top mentions in Dr. Reddy's Reviews
+ 5 more
Compare Dr. Reddy's with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 4.1/5 based on 6.7k reviews | 3.9/5 based on 1.9k reviews | 4.0/5 based on 5.7k reviews | 4.1/5 based on 6.8k reviews |
Highly Rated for | Skill development Company culture Work-life balance | Work-life balance Job security | Salary Skill development Job security | Skill development Salary Work-life balance |
Critically Rated for | No critically rated category | Promotions | No critically rated category | No critically rated category |
Primary Work Policy | Work from office 75% employees reported | Work from office 85% employees reported | Work from office 81% employees reported | Work from office 73% employees reported |
Rating by Women Employees | 4.0 Good rated by 737 women | 3.9 Good rated by 279 women | 4.0 Good rated by 432 women | 4.1 Good rated by 674 women |
Rating by Men Employees | 4.1 Good rated by 5.7k men | 3.9 Good rated by 1.5k men | 4.0 Good rated by 5k men | 4.1 Good rated by 5.7k men |
Job security | 3.6 Good | 3.8 Good | 3.8 Good | 3.7 Good |
View more
Dr. Reddy's Salaries
Dr. Reddy's salaries have received with an average score of 3.8 out of 5 by 6.7k employees.
Team Member
(3.9k salaries)
Unlock
₹2 L/yr - ₹9.7 L/yr
Analytical Scientist
(821 salaries)
Unlock
₹3.6 L/yr - ₹12.5 L/yr
Senior Team Member
(544 salaries)
Unlock
₹3.8 L/yr - ₹13 L/yr
Team Lead
(464 salaries)
Unlock
₹7 L/yr - ₹24.2 L/yr
Area Sales Manager
(464 salaries)
Unlock
₹4.8 L/yr - ₹12.6 L/yr
Territory Manager
(326 salaries)
Unlock
₹2.5 L/yr - ₹7.2 L/yr
Scientist
(298 salaries)
Unlock
₹4 L/yr - ₹13.8 L/yr
Formulation Scientist
(261 salaries)
Unlock
₹4.2 L/yr - ₹12.4 L/yr
Research Associate
(249 salaries)
Unlock
₹2.9 L/yr - ₹10 L/yr
Production Specialist
(239 salaries)
Unlock
₹3.2 L/yr - ₹8 L/yr
Dr. Reddy's Interview Questions
Interview questions by designation
Top Dr. Reddy's interview questions and answers
Get interview-ready with top interview questions
Dr. Reddy's Jobs
Popular Designations Dr. Reddy's Hires for
Current Openings
Dr. Reddy's News
View all
Buy, Sell Or Hold: HAL, Bharti Airtel, SBI, BHEL, Zomato, Titan, Trent — Ask Profit
- Market analysts shared insights on whether to buy, sell or hold shares of various companies.
- HAL: Hold with a strict stoploss.
- SBI: Hold with a stoploss near Rs 725.
- Trent: Sell due to stretched valuations.
- ABB India: Sell and exit on some rise.
- Bharti Airtel: Hold and expect positive opening.
- Dr Reddy's Laboratories: Hold for more than five years.
- Titan Co.: Sell due to valuation concerns.
- BHEL: Sell and book profits.
- Zomato: Sell due to short-term pain in the stock and sector.
Bloomberg Quint | 6 Feb, 2025
RP Sanjiv Goenka Group elevates Janesh K to VP-group corporate HR
- RP Sanjiv Goenka Group has elevated Janesh K to the role of VP-group corporate HR.
- Janesh K moves from RP-SG FMCG (Guiltfree Industries) where he was CHRO since 2020.
- In his new role, Janesh will spearhead HR excellence initiatives and contribute to strategic HR programs.
- He will be based out of Kolkata.
HRKatha | 28 Jan, 2025
Dr Reddy’s shares plummet 4.4% in the wake of logging modest Q3 growth
- Dr Reddy’s Laboratories reported a 2% increase in net profit to ₹1,413 crore for Q3 2024.
- Total revenue rose 16% to ₹8,358 crore, attributed to the newly acquired NRT business, new product launches, and improved operational efficiencies.
- North American revenues grew marginally by 1% to ₹3,380 crore, while European revenues surged 143% due to the NRT business.
- Dr Reddy’s launched Toripalimab, an immuno-oncology drug, and completed a share capital alteration by splitting existing shares.
HinduBusinessLine | 24 Jan, 2025
Dr Reddy’s and Dr Reddy’s Foundation open soil testing resource centre
- Dr Reddy’s and Dr Reddy’s Foundation have opened a soil testing resource centre.
- The centre aims to promote sustainable agricultural practices and enhance productivity.
- The facility offers crop-specific, cost-effective recommendations based on accurate analysis of over 18 parameters.
- This initiative can help address the degradation of land and improve yields by 20-30%.
HinduBusinessLine | 17 Jan, 2025
Dr Reddy’s and Dr Reddy’s Foundation open soil testing resource centre
- Dr Reddy’s and Dr Reddy’s Foundation have opened a soil testing resource centre to promote sustainable agricultural practices and enhance productivity.
- The centre aims to address the gap in soil testing in the country and provide crop-specific, cost-effective recommendations.
- With advanced instruments and systems, the centre can accurately analyze over 18 parameters and process up to two lakh samples annually.
- Accurate soil testing plays a critical role in improving yields, reducing costs, and enhancing environmental outcomes by assessing soil characteristics and guiding informed decision-making.
HinduBusinessLine | 17 Jan, 2025
Stocks To Buy Today: Dr Reddy's, BHEL HCC, Aurobindo Pharma And More
- Analysts have shared 'buy' calls on BHEL, HCC, Dr Reddy's, Aurobindo Pharma, IPCA Labs, and Laurus Labs.
- Some of these companies could see upside of as much as 9% in the near term from current levels.
- Top stocks to buy, as recommended by experts: Dr Reddy's Laboratories, Aurobindo Pharma, Laurus Labs, HCC, IPCA Laboratories.
- Stocks like Dr Reddy's and Aurobindo Pharma have shown significant gains in the past 12 months.
Bloomberg Quint | 30 Dec, 2024
Markets end higher as pharma stocks lead gains; Sensex at 78,699
- The BSESensex closed at 78,699.07, up 226.59 points or 0.29 per cent, while the NSENifty 50 gained 63.20 points or 0.27 per cent to end at 23,813.40.
- Dr Reddy’s Laboratories emerged as the top gainer on the NSE, rising 2.72 per cent, followed by IndusInd Bank at 2.37 per cent, Mahindra & Mahindra at 2.23 per cent, Tata Motors at 1.78 per cent, and Eicher Motors at 1.51 per cent.
- Hindalco led the losses with a 1.73 per cent decline, followed by State Bank of India at 1.43 per cent, Coal India at 1.40 per cent, ONGC at 1.31 per cent, and Bharat Electronics Limited at 1.02 per cent.
- The broader market indices underperformed the benchmarks, with the Nifty Next 50 declining 0.88 per cent to 68,557.15 and the Nifty Midcap Select falling 0.18 per cent to 12,768.90.
HinduBusinessLine | 27 Dec, 2024
Trading Ideas: Don't Buy Axis Bank, NCC At Current Levels, Say Stock Market Experts
- Stock market experts advise against buying Axis Bank and NCC at current levels.
- Kushal Gandhi suggests avoiding Axis Bank as it has been on a downtrend with selling pressure sustaining.
- Sameer Dalal recommends buying NCC at lower levels, expecting a decent return over the next two years.
- Dalal advises investors to switch from Abbott India to Dr Reddy's Laboratories due to the latter's larger growth opportunity.
Bloomberg Quint | 20 Dec, 2024
Markets extend losses as Banks, IT lead decline; Dr Reddy’s bucks trend
- Market breadth remained negative with 2,187 stocks declining versus 1,659 advances on the BSE.
- Banking stocks continued to slide, with Axis Bank and IndusInd Bank among the top losers.
- Dr Reddy’s Laboratories led the gainers on the Nifty, followed by Hindalco Industries.
- Tech Mahindra, Larsen & Toubro, and UltraTech Cement were among the significant losers.
HinduBusinessLine | 20 Dec, 2024
Sensex plunges 964 points as Fed’s hawkish stance sparks market sell-off
- Sensex plunges 964 points as Fed’s hawkish stance sparks market sell-off
- Dr Reddy’s, Cipla, BPCL, Sun Pharma, and Apollo Hospitals emerge as gainers
- Banking and financial services sectors witness significant decline
- Market volatility increases with circuit filters triggered for multiple stocks
HinduBusinessLine | 19 Dec, 2024
Powered by
Dr. Reddy's Subsidiaries
Aurigene Oncology Limited
4.3
• 242 reviews
Aurigene Pharmaceutical Services
4.2
• 222 reviews
SVAAS Wellness
3.8
• 13 reviews
Report error
Dr. Reddy's Offices
Compare Dr. Reddy's with
Lupin
4.2
Zydus Lifesciences
4.1
Glenmark Pharmaceuticals
3.9
Torrent Pharmaceuticals
3.9
Aurobindo Pharma
4.0
DIVI'S Laboratories
3.8
Alembic Pharmaceuticals
4.0
Intas Pharmaceuticals
4.1
Hetero
3.9
Viatris
4.2
Abbott
4.1
Alkem Laboratories
3.9
Ipca Laboratories
3.9
MSN Laboratories
3.7
Ajanta Pharma
4.1
Akums Drugs & Pharmaceuticals Limited
4.4
Cadila Pharmaceuticals
3.5
GlaxoSmithKline Pharmaceuticals
4.1
Pfizer
4.0
Wockhardt
3.9
Contribute & help others!
You can choose to be anonymous
Companies Similar to Dr. Reddy's
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.0
• 5.7k reviews
Cipla
Manufacturing, Pharma
4.1
• 6.8k reviews
Biocon Limited
Biotech & Life sciences, Biotechnology
3.9
• 1.9k reviews
Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.2
• 6k reviews
Zydus Lifesciences
Biotech & Life sciences, Pharma
4.1
• 5.9k reviews
Glenmark Pharmaceuticals
Pharma
3.9
• 2.8k reviews
Torrent Pharmaceuticals
Pharma
3.9
• 2.5k reviews
Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 4.7k reviews
DIVI'S Laboratories
Pharma
3.8
• 1.4k reviews
Alembic Pharmaceuticals
Real Estate, Engineering & Construction, Biotechnology, Pharma
4.0
• 3k reviews
Intas Pharmaceuticals
Biotech & Life sciences, Pharma
4.1
• 3.4k reviews
Hetero
Clinical Research, Healthcare, Pharma
3.9
• 3.2k reviews
Dr. Reddy's FAQs
When was Dr. Reddy's founded?
Dr. Reddy's was founded in 1984. The company has been operating for 41 years primarily in the Pharma sector.
Where is the Dr. Reddy's headquarters located?
Dr. Reddy's is headquartered in Hyderabad/Secunderabad, Telangana. It operates in 6 cities such as Hyderabad / Secunderabad, Visakhapatnam, Baddi, Srikakulam, Bangalore / Bengaluru. To explore all the office locations, visit Dr. Reddy's locations.
How many employees does Dr. Reddy's have in India?
Dr. Reddy's currently has more than 21,000+ employees in India. Research & Development department appears to have the highest employee count in Dr. Reddy's based on the number of reviews submitted on AmbitionBox.
Does Dr. Reddy's have good work-life balance?
Dr. Reddy's has a Work-Life Balance Rating of 3.8 out of 5 based on 6,700+ employee reviews on AmbitionBox. 80% employees rated Dr. Reddy's 4 or above, while 20% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Dr. Reddy's work-life balance reviews for more details
Is Dr. Reddy's good for career growth?
Career growth at Dr. Reddy's is rated as moderate, with a promotions and appraisal rating of 3.4. 20% employees rated Dr. Reddy's 3 or below, while 80% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Dr. Reddy's promotions/appraisals reviews for more detailed insights.
What are the pros of working in Dr. Reddy's?
Working at Dr. Reddy's offers several advantages that make it an appealing place for employees. The company is highly rated for skill development, company culture and salary & benefits, based on 6,700+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
